. Chemiluminescent measurements of nitric oxide pulmonary diffusing capacity and alveolar production in humans. J Appl Physiol 91: 1931Physiol 91: -1940Physiol 91: , 2001.-Measurements of nitric oxide (NO) pulmonary diffusing capacity (DLNO) multiplied by alveolar NO partial pressure (PANO) provide values for alveolar NO production (V ANO). We evaluated applying a rapidly responding chemiluminescent NO analyzer to measure DLNO during a single, constant exhalation (DexNO) or by rebreathing (DrbNO). With the use of an initial inspiration of 5-10 parts/ million of NO with a correction for the measured NO back pressure, DexNO in nine healthy subjects equaled 125 Ϯ 29 (SD) ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 and DrbNO equaled 122 Ϯ 26 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 . These values were 4.7 Ϯ 0.6 and 4.6 Ϯ 0.6 times greater, respectively, than the subject's singlebreath carbon monoxide diffusing capacity (Dsb CO). Coefficients of variation were similar to previously reported breath-holding, single-breath measurements of Dsb CO. PANO measured in seven of the subjects equaled 1.8 Ϯ 0.7 mmHg ϫ 10 Ϫ6 and resulted in V ANO of 0.21 Ϯ 0.06 l/min using DexNO and 0.20 Ϯ 0.6 l/min with DrbNO. DexNO remained constant at end-expiratory oxygen tensions varied from 42 to 682 Torr. Decreases in lung volume resulted in falls of Dex NO and Drb NO similar to the reported effect of volume changes on DsbCO. These data show that rapidly responding chemiluminescent NO analyzers provide reproducible measurements of DL NO using single exhalations or rebreathing suitable for measuring V ANO. alveoli; rebreathing THE RESPIRATORY TRACT PRODUCES nitric oxide (NO) in the nasal pharynx, the conducting airways, and the alveoli (10, 13, 24) . Recently developed methods permit determination of the rate of NO production from these three locations (10, 24, 30) . Representative values in normal subjects are 0.4 l/min for the nose and nasal pharynx (10, 11), 0.08 l/min from the conducting airways (24, 30), and 0.2 l/min from the alveoli (24). The most popular method to estimate NO production by the conducting airways is based on measurement of expired NO concentration at constant expiratory flow rates from 50 to 200 ml/min while the subject exhales against a positive pressure of 5-20 cmH 2 O (26). The positive pressure excludes contamination of the expired samples from NO in the nasal pharynx. At these relatively slow expiratory flow rates, the expired NO concentrations mainly reflect the NO production by the conducting airways, with little contribution from the alveoli. Airway inflammation from bronchial asthma can cause dramatic increases of conducting airway NO (26). Measurements of expired NO have attracted interest as a means to monitor airway inflammation and investigate the mechanisms controlling NO production by the conducting airways (26).
subjects are 0.4 l/min for the nose and nasal pharynx (10, 11) , 0.08 l/min from the conducting airways (24, 30) , and 0.2 l/min from the alveoli (24) . The most popular method to estimate NO production by the conducting airways is based on measurement of expired NO concentration at constant expiratory flow rates from 50 to 200 ml/min while the subject exhales against a positive pressure of 5-20 cmH 2 O (26). The positive pressure excludes contamination of the expired samples from NO in the nasal pharynx. At these relatively slow expiratory flow rates, the expired NO concentrations mainly reflect the NO production by the conducting airways, with little contribution from the alveoli. Airway inflammation from bronchial asthma can cause dramatic increases of conducting airway NO (26) . Measurements of expired NO have attracted interest as a means to monitor airway inflammation and investigate the mechanisms controlling NO production by the conducting airways (26) .
Determination of NO production by the alveoli (V A NO ) is more complex. It requires measurements of expired NO concentration collected while the subject expires against a positive pressure of 5-20 cmH 2 O at a number of different constant expiratory flow rates (24, 29, 30) . These measurements permit extrapolation to the NO concentration present at an infinitely fast expiratory flow rate that is free of any contribution from the conducting airways to the expired air. This extrapolated value represents the alveolar NO partial pressure (PA NO ) present during a steady state without entry of NO into the alveoli from the conducting airways. PA NO multiplied by the pulmonary NO diffusing capacity (DL NO ) equals V A NO (15) or V A NO ϭ PA NO ⅐ DL NO (1)
To date, V A NO has only been measured in normal human subjects (24) , but it is suspected to be elevated in some diseases, such as cirrhosis of the liver (19) , while decreased in other diseases, such as primary pulmonary hypertension (8) .
Measurements of V A NO require a measurement of DL NO (Eq. 1). In humans, several groups have measured DL NO with a modification of the carbon monoxide (CO) breath-holding, single-breath method (Dsb CO ) (2, 3, 12, 18) . Short breath-holding times of 3-8 s were required because the rapid clearance of NO from the alveoli prevented accurate measurements of the small expired NO signal after 10 s of breath holding. The shorter breath-holding periods make it difficult to determine accurately the breath-holding time interval. In the past decade, rapidly responding, highly sensitive chemiluminescent NO analyzers have become available that permit continuous breath-by-breath measurements of NO concentration during the ventilatory cycle.
The purpose of this report is to see if these analyzers can be applied to make accurate measurements of DL NO suitable for calculating V A NO . We describe a single exhalation method and rebreathing method that do not require a concurrent measurement of an inert, relatively insoluble gas, such as helium or methane. Compared with the breath-holding techniques, advantages include the use of lower concentrations of NO in the order of 5-10 ppm and the elimination of errors from estimating the breath-holding time interval. These methods are also compared with Dsb CO obtained in the same subjects.
Glossary

CV
Coefficient of variation Dex CO Pulmonary CO diffusing capacity measured during a single, constant maximum exhalation Dex NO Pulmonary NO diffusing capacity measured during a single, constant maximum exhalation DL Pulmonary diffusing capacity; test gas not specified DL CO Pulmonary CO diffusing capacity; method of measurement not specified DL NO Pulmonary NO diffusing capacity Drb CO Pulmonary CO diffusing capacity measured during rebreathing CO Drb NO Pulmonary NO diffusing capacity measured during rebreathing NO Dsb CO Breath-holding, single-breath CO diffusing capacity Dsb NO Breath-holding, single-breath NO diffusing capacity PA NO Partial pressure of NO in alveoli PNO ex Expired concentration of NO PNO exϱ Minimal partial pressure of NO that can be present during measurements of Dex NO PNO rbϱ Minimal partial pressure of NO that can be present during measurements of Drb NO VA Alveolar volume V A NO NO production by the alveoli
METHODS
Measurement of NO.
Details of the method to measure NO have been previously described (11, 24) . A rapidly responding chemiluminescent NO analyzer (model 270B, Sievers, Boulder, CO), operating at a sample rate of 250 ml/min, continuously measured exhaled levels of NO at the mouthpiece. Response time of the analyzer was Ͻ200 ms for a signal of 90% full scale with a lag time of 0.8 s. The analyzer was adjusted to provide 40 measurements of the NO concentration per second that could be averaged over any time interval. The NO analyzer was calibrated daily by serial dilution of a gas containing 229 parts per billion (ppb) of NO. To obtain reference gas samples free of NO, air from a gas cylinder containing Ͻ2 ppb of NO (Scott Specialty Gases, Plumsteadville, PA) was passed through a filter packed with potassium permanganate (Purafil, Thermoenvironmental Instruments, Franklin, MA).
Measurements of this NO-free air were performed within 2 min before and after each NO measurement of expired gas samples and averaged to obtain the zero NO signal. The lag time between the volume signal obtained from the potentiometer attached to the spirometer and change in the NO signal caused mainly by the transit time through the NO sampling tube was determined daily and equaled 0.8 Ϯ 0.1 (SD) s. Multiple repetitive measurements of gas mixtures of 2.8 and 8.2 mmHg ϫ 10 Ϫ6 of NO showed a SD of 0.09 mmHg ϫ 10 Ϫ6 . During gas sampling, the operator exhaled warm humidified gas from the mouth by the inlet of the NO analyzer every ϳ5-10 min; thus the walls of the unheated tygon inlet tubing (150 cm in length with an inside diameter of 1.6 mm and an outside diameter of 3.2 mm) were kept moist. This resulted in all gases being considered measured at ATPS. The chart recorder (MACLab Recording Instrument, AD, Castle Hill, NSW, Australia) stored the volume signal and NO signal in a Macintosh LC computer (Apple Computer, Cupertino, CA).
Single, rapid, maximal exhalation at constant flow rate for measuring DL NO. After resting for 5 min in the sitting position, each subject first exhaled to residual volume (RV) through the mouthpiece of the apparatus attached to a fourway valve connected to room air (Fig. 1) . The valve was turned 90°, and the subject rapidly inhaled 5-10 ppm of NO from the bag-in-box to total lung capacity, breath held for 2-3 s, and then exhaled into the spirometer at an expiratory flow rate of 460 Ϯ 80 (SD) ml/s (range: 370-560 ml/s) to RV. For most of the measurements, the constant expiratory flow rate was facilitated by narrowing the expiratory line to the spirometer with a cork penetrated by an open tube with a cross-sectional area of 12 mm 2 . The subject was instructed to maintain an expiratory pressure of ϩ5 cmH2O observed on the water manometer attached at the mouthpiece. The concentration of NO at the mouthpiece and changes in lung volume were recorded (Fig. 2) . DLNO measured during a single, constant maximum exhalation (DexNO) was calculated by using a modification of the method described by Cotton and coworkers (6) . At any instant, the amount of NO leaving the alveolar volume (VA) equals the amount of NO diffusing into the blood or
where DexNO is recorded in ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , PNOex is the partial pressure of NO at any instant in the expired gas measured at the mouth in mmHg, VA is expressed in ml STPD, PB is barometric pressure, and PNOexϱ is the minimal partial pressure of NO that can be present during the measurement whose subtraction corrects for NO production by the alveoli. Integration gives
where PNOex1 and PNOex2 are the initial and final values of PNOex during the time interval t2 Ϫ t1 recorded in seconds during the exhalation. The computer calculated DexNO every 0.025 s and then averaged this value with the previous 19 values, so that a value of DexNO was recorded as a 0.5-s moving average plotted every 0.025 s (Fig. 3) . A single value for DexNO for each exhalation was then calculated from the mean of these values for DexNO, which was obtained after the initial data were discarded that was measured during exhaling of a volume equal to four times the total dead space, which was calculated as the sum of the subject's estimated anatomic dead space and the instrument's dead space of 100 ml. The subject's anatomic dead space was assumed to equal the subject's ideal body weight in pounds and was expressed in milliliters (4) . The final 15% of the exhaled vital capacity was also discarded.
The VA at any instant was calculated by the computer using the subject's RV plus the remaining fraction of the exhaled vital capacity recorded by the spirometer. RV was obtained from the subject's functional residual capacity measured with a body plethysmograph (9) , less the expiratory reserve volume measured with a spirometer.
Estimation of the back pressure or PNO exϱ. The subjects repeated the same maneuver used to measure DexNO with the bag-in-box filled with room air containing Ͻ15 ppb of NO. PNOexϱ was calculated from the mean value of the expired NO concentration that was recorded after the initial NO signal was discarded that was obtained while the subject exhaled a volume equal to four times the total dead space calculated as described above, as well as the final 10% of the expired Fig. 1 . Diagram of apparatus used to measure nitric oxide (NO) diffusing capacity with single, constant exhalations (DexNO) and rebreathing (DrbNO). For measuring DexNO, the subject inhaled 5-10 parts/million (ppm) of NO from the bag-in-box, breath held for 2-3 s, and then exhaled through the orifice of the cork while maintaining ϩ5 cm of pressure in the manometer. The cork and manometer result in a constant expiratory flow rate of ϳ0.5 l/s. To measure DrbNO, the cork and manometer were removed, and subjects rebreathed 5-10 ppm of NO placed in the bag, emptying the bag at the end of each inspiration. For details see text.
Fig. 2. Recording of NO signal and change in lung volume during the measurement of DexNO. The subject rapidly inhaled 3.3 liters of NO-enriched air, breath held for 3 s, and then exhaled at a constant flow rate of 370 ml/s. DexNO was calculated from the data collected after discarding an initial volume equal to 4 times the subject's and instrument's dead space (4 ϫ DS) and the final 15% of the expired vital capacity (15% VC). volume. For six of the subjects, measurements of PNOexϱ were made at several different constant expiratory flow rates above and below the flow rate used to measure DexNO. This allowed extrapolation to a value of PNOexϱ that matched the expiratory flow rate present during the measurement of DexNO.
Rebreathing method for measuring DLNO. The rebreathing maneuver was performed by first filling the bag-in-box with 5-10 ppm of NO in air at a gas volume of ϳ1 liter less than the subject's vital capacity. The subject inserted the mouthpiece and exhaled into the room to RV. The valve at the mouthpiece was turned to the bag, and the subject inspired the contents of the bag and then rebreathed 1.6 Ϯ 0.3 liters (STPD) at a constant rebreathing rate of 23 Ϯ 4 breaths/min, emptying the bag with each breath for 20-30 s (Fig. 4 , top and middle). The computer transformed the NO signal to a plot of the natural logarithm of the partial pressure of NO at the mouth less the minimal partial pressure of NO present during rebreathing (PNO rbϱ) vs. time (Fig. 4, bottom) , where PNOrbϱ is calculated as described below. After one to three breaths, there is a linear decrease in the logarithm of this NO signal for the subsequent six to eight breaths, and these data were used to calculate rebreathing DLNO DrbNO. Data collected after 20 s of rebreathing were usually discarded because of the low signal-to-noise ratio at NO concentrations Ͻ30 mmHg ϫ 10 Ϫ6 (Fig. 4 , bottom). The operator measured the bag concentration (Pbag) recorded at the end of inspiration and the end-expiratory concentration (PNOex) of these breaths. The computer calculated the slope of two parallel lines fitted to Pbag Ϫ PNOrbϱ and PNOex Ϫ PNOrbϱ (kNO) expressed as a fractional change in concentration per minute. From two parallel lines drawn through Pbag Ϫ PNOrbϱ and PNOex Ϫ PNOrbϱ, the ratio of Pbag Ϫ PNOrbϱ to PNOex Ϫ PNOrbϱ at any instant (H) was calculated (Fig. 4) . DrbNO was then calculated with an equation similar to equations derived by Hook and Meyer (14) and Meyer and coworkers (21) that were used for calculating rebreathing measurements of oxygen, CO, and NO diffusing capacity (see APPENDIX for derivation)
where V tot is the total gas volume in ml (STPD) in the rebreathing circuit, which consists of the subject's RV, the gas volume of the initial inspiration, and the instrument's dead space of 100 ml. V eff is effective ventilation in ml/min during rebreathing and was calculated as the mean volume of the rebreathing breaths less the instrument's dead space of 100 ml and the subject's dead space, which is estimated to be 25% of the rebreathing volume (23) multiplied by the rebreathing rate in breaths/min. Estimation of the PNO rbϱ. PNOrbϱ during rebreathing was measured by having the subject perform the same rebreathing maneuver for 15-20 s with the bag-in-box filled with room air. After 5-10 s of rebreathing, the NO concentration reaches a constant value equal to PNO rbϱ (see Fig. 4 in Ref.
11). The value for PNOrbϱ was measured from the mean NO concentration recorded at the mouth during the last 3 s of rebreathing after discarding the final exhalation during rebreathing (11) . In seven of the subjects, the rebreathing maneuver to measure PNO rbϱ was performed at ventilatory rates above and below the value present for measuring DrbNO. These measurements permitted extrapolation to a value for PNOrbϱ that matched the ventilatory rate present during the measurement of DrbNO.
Effects of alveolar oxygen tension on DexNO. Five of the subjects performed measurements of DexNO at end-expiratory oxygen tensions varying between 42 and 570 Torr. Endexpiratory O2 was measured with an oxygen sensor (AG-17 O2 sensor, Ceramatec, Salt Lake City, UT; and TED200-TX microprocessor, Teledyne, City of Industry, CA) installed in the expiratory line of the apparatus (Fig. 1) . To vary the end-expiratory partial pressure of O2, the bag-in-box was filled with O2 concentrations varying from 1 to 99% before the NO was added just before the measurement of DexNO. To obtain end-expired O2 tensions in excess of 500 Torr, the subject performed three slow vital capacity maneuvers while inhaling 100% oxygen before inhaling 5-10 ppm NO in 99% oxygen. DexNO was calculated as described above.
Effects of VA on DexNO and DrbNO. Effects of changes in VA on DexNO were determined by comparing its value obtained during the first 20% of the expirate used to calculate DexNO to the final 20% (Fig. 3) . Six of the subjects decreased their VA during measurements of DrbNO by starting the initial inspiration from RV, with the rebreathing bag containing a volume reduced to 2-3 liters less than the subject's vital capacity.
Measurement of Dsb CO. DsbCO was measured by the technique of Jones and Meade (16) using automated equipment (P. K. Morgan, Haverhill, MA). DsbCO was multiplied by 5 to provide an estimated value of NO diffusing capacity (5 ϫ DsbCO). The factor 5 was chosen on the basis of published reports showing a ratio of NO diffusing capacity to CO dif- Middle: changes in lung volume during rebreathing. The subject inspired 4.6 liters and then rebreathed 1.6 liters for 34 s. Bottom: the oscillating signal is the computer-processed NO concentration recorded as the difference between NO concentration at the mouth (PNO) less the minimal partial pressure of NO present during rebreathing (PNOrbϱ). This signal is plotted as the logarithm of PNO Ϫ PNOrb vs. time. After the first 2 breaths were discarded, the computer fitted 2 straight, parallel, dashed lines to the inspired concentration from the breathing bag (top dashed line) and the end-expiratory concentration (bottom dashed line). The slope of these lines (kNO) and the ratio of the concentration of the 2 dashed lines at any instant (H) were used to calculate DrbNO with Eq. 4. In this subject, H can be calculated at time 0 and equaled 9.0 ϫ 10 3 Ϭ 3.2 ϫ 10 3 , or 2.8.
fusing 18, 28, 31) . Measurement of V ANO. V ANO is the product of PANO and the diffusing capacity for NO (Eq. 1). PANO for seven of the subjects was measured with the technique described by Pietropaoli and coworkers (24) , where subjects performed a series of exhalations at different constant expiratory flow rates after inspiring room air and breath holding for 10-15 s. The faster the exhalation, the less is the contribution of the NO produced by the conducting airways to the NO originating from the alveoli (PA NO). The expired NO concentration in a series of expirations at different expiratory flow rates permits extrapolation to the concentration of NO at an infinite expiratory flow rate. This value was considered to be PA NO free of contamination by NO from the conducting airways. V ANO was then calculated with Eq. 1.
Subjects. Measurements of DexNO, DrbNO, and DsbCO were made in nine healthy, nonsmoking subjects ranging in age from 31 to 72 yr (mean 46 Ϯ 18 yr). Height was 173 Ϯ 9 cm, and weight was 73 Ϯ 11 kg. Six were men, and three were women. All subjects were free of cardiopulmonary disease and respiratory symptoms. Spirometry showed values of Ն90% of predicted (7) for the forced expiratory volume in 1 s with a mean value of 106 Ϯ 14% of the predicted forced expiratory volume in 1 s. The study was approved by the University of Rochester's Research Subjects Review Board.
Statistical methods. Results are given as means Ϯ SD. In experiments in which subjects served as their own control, results were compared using a two-tailed paired t-test. Groups of subjects were compared with an unpaired t-test. A P value Ͻ 0.05 was required for statistical significance. NO , Drb NO , and Dsb CO . Figure 5 shows the individual values for Dex NO , Drb NO , and Dsb CO multiplied by 5 in the nine subjects. Dex NO equaled 125 Ϯ 29 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , Drb NO equaled 122 Ϯ 26 ml ⅐ min Ϫ1 ⅐ mmHg
RESULTS
Values for Dex
Ϫ1
, and 5 ϫ Dsb CO equaled 135 Ϯ 36 ml ⅐ min Ϫ1 ⅐ mmHg
. The 3% difference between Dex NO and Drb NO reached statistical significance (P ϭ 0.046). Dex NO was 4.7 Ϯ 0.6 times greater than Dsb CO , and Drb NO was 4.6 Ϯ 0.6 times greater than Dsb CO . NO and Drb NO . Table 1 shows interday and intraday variability of Dex NO and Drb NO expressed as the coefficient of variation (CV). Intraday CV in the nine subjects for Dex NO was 4.4 Ϯ 3.9% and for Drb NO was 3.4 Ϯ 1.9%. Interday CVs were slightly larger at 8.1 Ϯ 4.9% for Dex NO measured in seven of the subjects and 13.6 Ϯ 10.1% for Drb NO measured in six of the subjects.
Intraday and interday variability of Dex
Influence of alveolar oxygen tension on Dex NO . Figure  6 shows values for Dex NO at end-expiratory O 2 tensions that varied from 42 to 682 Torr in five of the subjects. Dex NO showed no consistent change with different oxygen tensions. For example, the mean values for the five subjects obtained Ͻ100 Torr at 60 Ϯ 10 Torr equaled 126 Ϯ 30 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 compared with 128 Ϯ 31 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 for all measurements at values Ͼ450 Torr obtained at 557 Ϯ 68 Torr and did not differ significantly (P ϭ 0.14).
Effects of changes in VA on Dex NO and Drb NO . Figure  7A shows values for Dex NO determined from the first 20% and the final 20% of the expirate used to determine PNO ex in nine subjects. Dex NO fell from 138 Ϯ 35 to 100 Ϯ 21 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , or 28% (P ϭ 0.001), with a change in VA from 6,578 Ϯ 1,508 to 4,714 Ϯ 1,112 ml BTPS. Figure 7B shows the changes for Drb NO performed at VA values of 6,186 Ϯ 791 and 4,682 Ϯ 373 ml BTPS in six of the subjects. Drb NO fell from 127 Ϯ 30 to 107 Ϯ 21 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , or 19% (P ϭ 0.050). V A NO in humans. In seven of the subjects, V A NO was calculated from the product of PA NO with Dex NO , Fig. 5 . Values for DexNO, DrbNO, and 5 times the carbon monoxide breath-holding, single-breath diffusing capacity (5 ϫ DsbCO) for 9 normal subjects. DLNO, pulmonary lung diffusing capacity of NO. Symbols are as follows: E, subject MC (31 yr, male); ᮀ, subject AP (33 yr, male); F, subject AT (33 yr, male); {, subject JB (34 yr, male); OE, subject PP (72 yr, male); }, subject RH (68 yr, male); s, subject CG (32 yr, female); , subject IP (32 yr, female); ‚, subject SH (65 yr, female). NO 
expressed as coefficients of variation
Intraday CV, % Interday CV, % DexNO 4.4 Ϯ 3.9 (n ϭ 9) 8.1 Ϯ 4.9 (n ϭ 7) DrbNO 3.4 Ϯ 1.9 (n ϭ 9) 13.6 Ϯ 10.1 (n ϭ 6)
Values are means Ϯ SD; n, no. of subjects. CV, coefficient of variation; DexNO, NO diffusing capacity measured during a single exhalation; DrbNO, NO diffusing capacity measured during rebreathing. Drb NO , and 5 ϫ Dsb CO (Fig. 8) . PA NO equaled 1.8 Ϯ 0.7 mmHg ϫ 10 Ϫ6 . The respective values of V A NO were 0.21 Ϯ 0.06, 0.20 Ϯ 0.06, and 0.22 Ϯ 0.06 l/min. The small difference between V A NO calculated with Dex NO and Drb NO was significant (P ϭ 0.009).
PNO exϱ and PNO rbϱ or back pressure. PNO exϱ equaled 3.8 Ϯ 1.7 mmHg ϫ 10 Ϫ6 and PNO rbϱ equaled 2.6 Ϯ 0.7 mmHg ϫ 10 Ϫ6 . If PNO exϱ and PNO rbϱ were assumed to equal zero, Dex NO was underestimated by 2.3 Ϯ 1.6% (P ϭ 0.002) and Drb NO by 1.7 Ϯ 0.9% (P ϭ 0.0002).
DISCUSSION
These data show that rapidly responding chemiluminescent NO analyzers, combined with simple pulmonary function equipment (Fig. 1) , permit reproducible measurements of DL NO in normal subjects using either single exhalations (Dex NO ) or rebreathing (Drb NO ). A separate measurement of the subject's RV with techniques such as body plethysmography or helium gas dilution is required. This measurement obviates the complexity of continuous analysis of an inert, insoluble gas such as helium with mass spectrometry, which was employed by previous investigators using single exhalations or rebreathing methods (6, 21, 28, 31) . These are the first measurements of DL NO that take into account the NO back pressure to diffusion resulting from NO production by the lungs. NO NO in the same subjects shown in a figure in their report (28) appear to be slightly lower at the same VA.
Comparison of breath-holding, single-breath NO diffusing capacity and Dex
The ratio of Dex NO to Dsb CO of 4.7 Ϯ 0.6 and Drb NO to Dsb CO of 4.6 Ϯ 0.6 in our subjects is similar to the values from the above breath-holding studies. Influence of NO back pressure on measurements of NO diffusing capacity. Production of NO by mammalian airways and its presence in exhaled air were not recognized until 1991 (13) . Therefore, previous measurements of NO diffusing capacity by breath holding in humans and rebreathing in animals did not take this NO back pressure into account. Unlike for CO, NO back pressure has two components. First is the production of NO by the pulmonary capillary endothelium and the alveolar-capillary membrane that results in a PA NO in the order of 2 ϫ 10 Ϫ6 mmHg (24, 30) . Second, during exhalation this NO is added to the NO production by the conducting airways. This concentration from the conducting airways is highly dependent on expiratory flow rates (24, 26, 30) , but typically at flow rates of 500 ml/s it equals ϳ4 ϫ 10 Ϫ6 mmHg (24) . Alveolar NO during the measurement of Dex NO or Drb NO falls rapidly, with a half-time in the order of 2-3 s; thus the background pressure can make an appreciable contribution to the expired NO concentration later in the maneuver. Our measurements of Dex NO and Drb NO performed with 5-10 ppm of NO would be underestimated by ϳ2% if the back pressure were ignored. If the inspired NO concentration were decreased threefold to 2-3 ppm, the estimated error from ignoring NO back pressure would increase to 5% for Dex NO and 3% for Drb NO . Initially, inhaling a fourfold higher concentration of NO of 40 ppm reduces the estimated error to 0.6% for Dex NO and 0.4% for Drb NO . Inhaling 80 ppm of NO reduced the error at 40 ppm in half. Therefore, inhaling 40-80 ppm of NO instead of the 5-10 ppm employed in our normal subjects would make the error from ignoring NO back pressure trivial. However, subjects with elevated levels of exhaled NO, such as observed in asthmatic subjects, may require measurements of NO back pressure to avoid underestimation of NO diffusing capacity, even with the initial inhalation of 40-80 ppm of NO.
Effect of changes in lung volume on Dex NO , Drb NO , and Dsb NO . Borland and Higenbottam (3) measured the effects of decreasing lung volume on Dsb NO in five of their subjects. A 44 Ϯ 9% decrease in VA decreased Dsb NO by 29 Ϯ 11%, resulting in a slope of 0.63 Ϯ 0.18 for the decrease in Dsb NO vs. the decrease in VA. This value is similar to the slope for Dex NO vs. VA of 0.95 Ϯ 0.44 and Drb NO vs. VA of 0.45 Ϯ 0.45 observed in our subjects. Recently, Tsoukias and coworkers (28, 31) completed a sophisticated analysis of the effects of VA and sequential filling on Dex NO . For the mean change of VA from 6.6 to 4.7 liters shown in Fig. 8 of their report (28) , seven normal subjects decreased Dex NO from 132 to 116 ml ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , resulting in a slope of 0.97. This value is in close agreement with the slope of 0.95 for VA vs. Dex NO found in our nine subjects.
Cause of lack of effect of changes in alveolar oxygen tension on Dsb NO and Dex NO . Borland and coworkers (3) observed no change in Dsb NO in five of their subjects when they varied alveolar oxygen concentration from 19 to 69%, whereas Dsb CO showed the expected fall from 34 to 20 ml⅐min Ϫ1 ⅐mmHg
Ϫ1
. We measured Dex NO over a wider range with end-expired oxygen concentrations varying from 6 to 96% and also observed no significant change in Dex NO . Lack of change in Dsb NO and Dex NO with the changes in oxygen tension has several explanations. First, unlike for CO, the very rapid rate of reaction of NO with oxyhemoglobin is similar to the reaction rate with reduced hemoglobin.
The bimolecular rate constant for the combination of NO with oxyhemoglobin is reported to be 3.4 ϫ 10 7 M/s vs. 2.2 ϫ 10 7 M/s with reduced hemoglobin (17). Therefore, the rate of uptake of NO by red blood cells should not be markedly altered by changes in pulmonary capillary oxygen saturation and, if anything, should increase with higher oxygen saturations. Second, as pointed out by Morris and Gibson (22) , the rate of reaction of NO with hemoglobin "is so high that effectively every molecule of NO which enters the reaction radius is captured by a heme group. The observed rate would then be a measure of diffusion to the site." Placing these concepts in the terminology developed by Roughton and Forster (25) for CO diffusion in the lungs, the uptake of NO by the pulmonary capillaries can be divided into its extra erythrocyte diffusion component and a reactive or intraerythrocyte component, V c ϫ ⌰ NO , where V c is the pulmonary capillary blood volume and ⌰ NO is the rate of combination of NO with the hemoglobin in 1 ml of blood measured in vitro. According to Morris and Gibson (22) , ⌰ NO has a finite value because of the time required for the advancing front of NO to travel within the blood cell to the combining site on the hemoglobin molecule. Because the chemical reaction of NO with hemoglobin is limited by diffusion to the combining site within the red blood cells but not by the chemical reaction with hemoglobin, the modest differences in the rate of combination of NO with O 2 hemoglobin compared with reduced hemoglobin should not alter ⌰ NO . As a result, DL NO measured at different alveolar O 2 concentrations remains constant.
Effects of parallel heterogeneity of lung VA, ventilation, and DL on Drb NO and Dex NO . Meyer and coworkers (21) performed an elegant analysis of the effects of uneven distribution of VA, ventilation (V E), and DL on measured values of Drb NO and rebreathing CO DL (Drb CO ) in dogs. In their model containing two parallel compartments, uneven distribution of VA between the compartments with the same DL-to-V E ratios caused overestimations of Drb NO and Drb CO , whereas uneven distribution of V E and DL resulted in underestimations. Most striking was their finding that all patterns of uneven distribution caused approximately twice as large an error in Drb NO compared with Drb CO .
Cotton and Graham (5) analyzed, in a similar two-compartment lung model, the effects of uneven distribution of V E, DL, and other factors on Dex CO . Dex CO was altered by nonuniform distribution of V E and DL. The errors caused by nonuniform V E could not be eliminated by recalculating the CO decay by reference to the simultaneously recorded helium concentration that was included in the inspired mixture. Models of effects of parallel heterogeneity of VA, V E, and DL on Dex NO have not been published to our knowledge. However, because the disappearance rate of NO from the alveoli is three to four times more rapid than that observed for CO, for any given pattern of uneven distribution, the difference in NO concentrations between the two compartments will be larger for NO, and the resulting errors in Dex NO will be greater than for Dex CO . Therefore, all methods of measuring diffusing capacity with NO can be expected to have errors from heterogeneity of VA, V E, and DL considerably larger than observed with methods using CO, such as reported by Meyer and coworkers (21) .
Measurements of V A NO require measurements of NO diffusing capacity (Eq. 1). Errors in DL NO from uneven distribution among VA, V E, and DL in the lungs will, therefore, result in similar errors in V A NO . DL CO and DL NO are not distorted to the same degree by uneven distribution. Therefore, errors from uneven distribution can be suspected if the ratio of DL NO to DL CO falls outside the usual range of 4.3-5.3 reported in healthy subjects. Measurements of DL NO have attracted interest as a measurement that more fully represents the diffusing properties of the alveolar capillary membrane by lessening the importance of red cell kinetics (20) . However, this theoretical advantage for DL NO may be reduced by its greater distortion by maldistribution of VA, V E, and DL within the lungs (21) .
Selection of method to measure DL NO for calculating V A NO . Three practical methods are now available to measure DL NO . They are single-breath measurement (Dsb NO ) with breath holdings usually between 3 and 8 s, the single, constant exhalation method (Dex NO ), and the rebreathing method (Drb NO ). Dsb NO has the advantage of off-line measurements of NO with analyzers with slow response times but requires analysis of an inert gas such as helium in the inspired gas and the expired alveolar sample. Accurate measurements of the short breath-holding time are critical, and, with longer breath holds, the resulting lower exhaled NO concentration is difficult to measure accurately. We found that Drb NO required considerable training even in normal subjects to obtain constant rebreathing rates and sufficient inspiratory effort with each breath to completely empty the rebreathing bag. For the measurement of Dex NO , the constant exhalation rate obtained by maintaining a mouth pressure of ϩ5 cmH 2 O against a fixed resistance in the expiratory circuit was easily achieved by normal subjects. We avoided higher expiratory pressures because they reduce CO diffusing capacity and, by inference, Dex NO (27) . Dex NO in our hands has proven to be a practical method for calculating V A NO in ongoing studies evaluating the potential toxic effects of inhaled particulates on the lungs. Dex NO has the added advantage of permitting measurements of NO diffusing capacity at different lung volumes (Fig. 3) . This may contribute useful information for detecting uneven distribution of DL NO within the lung. Whereas Dex NO and Drb NO do not require measurement of an inert insoluble gas during the maneuver, a separate measurement of RV is needed. All three methods have similar intraday and interday CV, except for Drb NO , which had a greater interday CV than the other methods (Refs. 3, 12; Table 1 ).
APPENDIX
Derivation of Equations for Computing DrbNO
Eq. 4 in METHODS is based on assumptions and equations similar to those published by Hook and Meyer (14) and Meyer and coworkers (21) .
While the subjects rebreathed from a bag enriched with NO Amount of NO entering the bag per min ϭ V eff FL (A1) Amount of NO leaving the bag per min ϭ V eff Fb (A2) where FL is the fractional concentration of NO in the lungs, Fb is the fractional concentration of NO in the rebreathing bag, and V eff is in ml/min STPD and is calculated as the rebreathing frequency times the rebreathing tidal volume, less the instrument's dead space of 100 ml and the subject's dead space, which is estimated to equal 25% of the rebreathing tidal volume (23) (see Fig. 9 ).
The NO leaving the bag during rebreathing is assumed to enter the lungs, and conversely the NO leaving the lungs by ventilation is assumed to enter the bag. Thus for the lungs during rebreathing Amount of NO entering the lungs per min
Amount of NO leaving the lungs per min
where V LNO is the rate of NO excretion by the lungs' tissues into the air spaces of the lungs in ml/min, DrbNO is measured in ml NO STPD ⅐ min Ϫ1 ⅐ mmHg Ϫ1 , and PL is partial pressure of NO in the lungs in Torr. Combining the above equations yields the following differential equations describing the changes in the NO concentration in the bag and the lungs during rebreathing. Fig. 9 . Diagram of events taking place during the rebreathing of a gas enriched with NO initially placed in the rebreathing bag of volume Vb that exchanges with the gas in the lungs of volume VL. Amount of NO entering the bag is FL (V eff) and amount leaving is Fb(V eff), where FL and Fb are the fractional concentrations of NO in the lungs and the bag, respectively, and V eff is the effective rate of ventilation between FL and Fb, as defined in the text. The lungs produce NO that enters VL (V LNO). NO diffuses from VL into the perfusing blood and surrounding tissues, and this amount of NO equals the product of partial pressure of NO in the lungs (PL) and DrbNO (Eq. 1).
For the lungs of volume VL in ml STPD
Because PL ϭ FL (PB Ϫ 47), the last two terms of Eq. A5 can be rearranged giving
During an infinitely long period of rebreathing, FL becomes constant at FLϱ (11) Ann Bauman contributed expert editorial assistance. This study was supported by National Institutes of Health Grants R01-HL-51701, R01-ES-02679, and T32-HL-07216.
